Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Withdrawn NGC Summaries

Use the index below to find guidelines (listed by guideline developer) that have been withdrawn from the NGC Web site. Select "All" to see a complete list of withdrawn NGC Guideline Summaries (organized alphabetically by guideline developer). For a list of guidelines that have been updated, go to Updated NGC Summaries.

Guideline summaries are removed from the NGC Web site because they no longer meet the NGC Inclusion Criteria with respect to date, or because the guideline developer has indicated that the clinical practice guideline upon which the summary is based is obsolete, should no longer be used, or has not yet been replaced with a new/revised guideline. Please refer to the guideline developer's Web site, where available, for more information.

Note to PC users: If you are not sure which developer you need, consider using the "Find" option under the Edit menu or select Control-F to search the complete list by keyword.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

The National Guideline Clearinghouse™ currently contains 1140 guidelines in the withdrawn archive.

Philadelphia Panel

  1. Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for knee pain. (NGC-4015)
    • Philadelphia Panel. Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for knee pain. Phys Ther 2001 Oct;81(10):1675-700. [98 references] PubMed

  2. Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for low back pain. (NGC-4016)
    • Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for low back pain. Phys Ther 2001 Oct;81(10):1641-74. [130 references] PubMed

  3. Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for neck pain. (NGC-4017)
    • Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for neck pain. Phys Ther 2001 Oct;81(10):1701-17. [85 references] PubMed

  4. Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for shoulder pain. (NGC-4018)
    • Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for shoulder pain. Phys Ther 2001 Oct;81(10):1719-30. [60 references] PubMed

PinnacleHealth

  1. Management of decision-making incapacity in nursing homes. (NGC-0459)
    • MacLean DS. Management of decision-making incapacity in nursing homes. Nurs Home Med 1996 Mar;4(3):78-92. [22 references]

For more information, please refer to the PinnacleHealth Web site.

Program in Evidence-based Care

  1. Accelerated radiotherapy for locally advanced squamous cell carcinoma of the head and neck. (NGC-2990)
    • Head and Neck Cancer Disease Site Group. Accelerated radiotherapy for locally advanced squamous cell carcinoma of the head and neck [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Oct [online update]. 19 p. (Practice guideline; no. 5-6c). [26 references]

  2. Adjuvant chemotherapy following complete resection of soft tissue sarcoma in adults. (NGC-4288)
    • Figueredo A, Bramwell VH, Bell R, Davis AM, Charette ML, Sarcoma Disease Site Group. Adjuvant chemotherapy following complete resection of soft tissue sarcoma in adults [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2005 Feb [online update]. 23 p. (Practice guideline report; no. 11-2). [43 references]

  3. Adjuvant therapy for stage II colon cancer following complete resection. (NGC-3462)
    • Gastrointestinal Disease Site Group. Figueredo A, Germond C, Maroun J, Browman G, Walker-Dilks C, Wong S. Adjuvant therapy for stage II colon cancer following complete resection [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Dec [online update]. 30 p. (Practice guideline report; no. 2-1). [70 references]

  4. Adjuvant therapy for stage III colon cancer following complete resection. (NGC-3463)
    • Gastrointestinal Cancer Disease Site Group. Figueredo A, Fine S, Maroun J, Walker-Dilks C, Wong S. Adjuvant therapy for stage III colon cancer following complete resection [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Dec [online update]. 34 p. (Practice guideline report; no. 2-2). [81 references]

  5. Altered fractionation of radical radiation therapy in the management of unresectable non-small cell lung cancer. (NGC-2825)
    • Lung Cancer Disease Site Group. Yu E, Lochrin C, Dixon P, Ung YC, Gagliardi A, Evans WK. Altered fractionation of radical radiation therapy in the management of unresectable non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Sep [online update]. 25 p. (Practice guideline; no. 7-12). [34 references]

  6. Breast irradiation in women with early stage invasive breast cancer following breast conserving surgery. (NGC-2426)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Breast irradiation in women with early stage invasive breast cancer following breast conserving surgery [full report]. Toronto (ON): CCOPGI; 2002 Jan [online update]. Various p. (Practice guideline report; no. 1-2). [61 references]

  7. Concomitant chemotherapy and radiotherapy in squamous cell head and neck cancer (excluding nasopharynx). (NGC-2215)
    • Browman GP, Hodson DI, Mackenzie RJ, Bestic N, Zuraw L, Cancer Care Ontario Practice Guidelines Initiative (CCOPGI). Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis. Head Neck 2001;23:579-89. [51 references]


    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Concomitant chemotherapy and radiotherapy in squamous cell head and neck cancer (excluding nasopharynx) [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Mar [online update]. Various p. (Practice guideline; no. 5-6a). [48 references]

  8. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. (NGC-3841)
    • Sarcoma Disease Site Group. Bramwell VH, Anderson D, Charette ML. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2004 Jul [online update]. 19 p. (Practice guideline report; no. 11-1). [27 references]

  9. Drug therapy for chronic myeloid leukemia. (NGC-2231)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Drug therapy for chronic myeloid leukemia [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2000 Jul [online update]. Various p. (Practice guideline; no. 6-3). [4 references]


    • Cancer Care Ontario Practice Guidelines Initiative. Drug therapy for chronic myeloid leukemia. Curr Oncol 2000;7(4):229-41. [28 references]

  10. Fludarabine in intermediate- and high-risk chronic lymphocytic leukemia. (NGC-2509)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Fludarabine in intermediate-and high-risk chronic lymphocytic leukemia [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Feb. Various p. (Practice guideline; no. 6-1). [45 references]

  11. Postoperative adjuvant radiotherapy and/or chemotherapy for resected stage II or III rectal cancer. (NGC-2508)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Postoperative adjuvant radiotherapy and/or chemotherapy for resected stage II or III rectal cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2001 Dec. Various p. (Practice guideline; no. 2-3). [51 references]

  12. Surveillance programs for early stage non-seminomatous testicular cancer. (NGC-2220)
    • Cancer Care Ontario Guideline Practice Initiative (CCOPGI). Surveillance programs for early stage non-seminomatous testicular cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2001 Jan [online update]. Various p. (Practice guideline; no. 3-5). [27 references]


    • Segal R, Lukka H, Klotz LH, Eady A, Bestic N, Johnston M, Genitourinary Cancer Disease Site Group, Cancer Care Ontario Practice Guidelines Initiative (CCOPGI). Surveillance programs for early stage non-seminomatous testicular cancer: a practice guideline. Can J Urol 2001 Feb;8(1):1184-92. [27 references] PubMed

  13. The treatment of locally advanced pancreatic cancer. (NGC-3079)
    • Gastrointestinal Cancer Disease Site Group. Earle CC, Agboola O, Maroun J, Zuraw L. The treatment of locally advanced pancreatic cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 May [online update]. 15 p. (Practice guideline; no. 2-7). [23 references]

  14. The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 prostate cancer. (NGC-2687)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI), Genitourinary Cancer Disease Site Group. Brundage M, Lukka H, Crook J, Warde P, Bauman G, Catton C, Markman BR, Charette M. The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 prostate cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Oct. 23 p. (Practice guideline; no. 3-11). [81 references]

  15. Treatment with fludarabine for patients with follicular and other low grade Non-Hodgkin’s Lymphoma and Waldenstrom’s Macroglobulinemia. (NGC-3528)
    • Hematology Disease Site Group. MacEachern J, Chin-Yee I, Imrie K, Esmail R, Makarski J, Meyer RM. Treatment with fludarabine for patients with follicular and other low grade non-Hodgkin's lymphoma and Waldenstrom's macroglobulinemia [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2001 Nov. 18 p. (Practice guideline report; no. 6-2). [31 references]

  16. Use of chemotherapy in advanced unresectable or metastatic transitional cell carcinoma of the bladder or urothelium. (NGC-3258)
    • Genitourinary Disease Site Group. Use of chemotherapy in advanced unresectable or metastatic transitional cell carcinoma of the bladder or urothelium [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Jun 19. 20 p. (Practice guideline; no. 3-12). [19 references]

  17. Use of gemcitabine in non-small cell lung cancer. (NGC-2828)
    • Lung Cancer Disease Site Group. Ellis P, Mackay JA, Evans WK. Use of gemcitabine in non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Sep. 29 p. (Practice guideline; no. 7-8). [49 references]

  18. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small cell lung cancer. (NGC-2507)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2002 Apr. Various p. (Practice guideline; no. 7-4).

  19. Use of strontium89 in patients with endocrine-refractory carcinoma of the prostate metastatic to bone. (NGC-2238)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of strontium89 in patients with endocrine-refractory carcinoma of the prostate metastaic to bone [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2001 Oct [online update]. Various p. (Practice guideline report; no. 3-6). [14 references]

  20. Use of vinorelbine in non-small cell lung cancer. (NGC-2428)
    • Cancer Care Ontario Practice Guideline Initiative (CCOPGI). Use of Vinorelbine in non-small cell lung cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2001 Aug [online update]. Various p. (Practice guideline; no. 7-5). [26 references]

For more information, please refer to the Program in Evidence-based Care Web site.